C. Lefeuvre et al., USEFULNESS OF RADIONUCLIDE VENTRICULOGRAPHY DURING TRANSESOPHAGEAL ATRIAL-PACING IN THE DIAGNOSIS OF CORONARY-ARTERY DISEASE, Angiology, 45(7), 1994, pp. 621-628
Citations number
23
Categorie Soggetti
Medicine, General & Internal","Cardiac & Cardiovascular System
Radionuclide ventriculography before, during, and after atrial transes
ophageal pacing was carried out in 15 patients with suspected coronary
artery disease (CAD) and without myocardial infarction. All patients
underwent coronary angiography. Ten patients (group 1) had a coronary
lesion > 50% on at least one of the main coronary arteries. Five patie
nts (group 2) had normal coronary arteries. Radionuclide left ventricu
lar ejection fraction (LVEF) before pacing was 56 +/-3% in group 1 and
59 +/-3% in group 2 (NS). Radionuclide ventriculography during pacing
was 45 +/-4% in group 1 (P < 0.0001 vs basal in group 1) and 45 +/-6%
in group 2 (P < 0.01 vs basal in group 2, NS vs group 1 during pacing
). Immediate postpacing ejection fraction did not differ in the two gr
oups and was identical to the prepacing value. A quantitative regional
wall motion analysis was performed in 105 segments. Regional radionuc
lide ventriculography was calculated in each segment as follows: end-d
iastolic counts - end-systolic counts/end-diastolic counts. The relati
ve decrease in regional LVEF during pacing was more important in the 3
9 segments related to a narrowed vessel than in the 66 segments relate
d to normal coronary artery (32 +/- 13% vs 13 +/- 10%, P < 0.0001). A
more than 20% relative decrease in at least one segment during pacing
occurred in 10 patients in group 1 (sensitivity 100%) and in 2 patient
s in group 2 (specificity 60%). In conclusion, global radionuclide ven
triculography during transesophageal atrial pacing decreases in patien
ts with and without CAD. In contrast, regional wall motion abnormaliti
es during pacing are more important in segments related to a narrowed
coronary artery and can be proposed for patients unable to exercise as
an alternative to pharmacologic stress test in the diagnosis of CAD.